Growth hormone cotreatment with gonadotropins in ovulation induction

Journal of Endocrinological Investigation

Volumn 19, Issue 11, 1996, Pages 763-779

  Artini, P G ^a   De Micheroux, A A ^a   D'Ambrogio, G ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

Growth hormone; Growth hormone releasing factor; Insulin like growth factors; Ovary; Ovulation induction; Polycystic ovaries; Poor responders

Indexed keywords

GONADOTROPIN; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; RECOMBINANT GROWTH HORMONE;

ADULT; ANOREXIA; ARTHRALGIA; CLINICAL TRIAL; DIARRHEA; DRUG MECHANISM; EDEMA; FATIGUE; FEMALE; HEADACHE; HORMONAL THERAPY; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; MAJOR CLINICAL STUDY; META ANALYSIS; NAUSEA; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PAIN; REVIEW; RIGIDITY; VOMITING;

EID: 0030468047     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03347881     Document Type: Review

References (128)

1. Sheikholislam B.M., Stempfel R.S. jr. Hereditary isolated somatotropin deficiency: effects of human growth hormone deficiency administration. Pediatrics 49:362, 1972.
2. Ramaley J.A., Phares C.K. Delay of puberty onset in females due to suppression of growth hormone. Endocrinology 106: 1989, 1980.
3. Darendeliler F., Hindmarsh P.C., Preece M.A., Cox L., Brook C.D. Growth hormone increases rate of pubertal maturation. Acta Endocrinol. (Copenh.) 122: 414, 1990.
4. Laron Z., Sarel R., Pertzelan A. Puberty in Laron type dwarfism. Eur. J. Pediatr. 134: 79, 1980.
5. Advis J.P., Smith-White S., Ojeda S.R. Activation of growth hormone short loop negative feedback delays puberty in the female rat. Endocrinology 108: 1343, 1981.
6. Menashe Y., Sack J., Mashiach S. Spontaneous pregnancies in two women with Larontype dwarfism: are growth hormone and circulating insulin-like growth factor mandatory for induction of ovulation? Hum. Reprod. 6: 670, 1991.
7. Moretti C., Fabbri A., Gnessi L., Bonifacio V., Bolotti M., Arizzi M., Nazzicone Q., Spera G. Immunohistochemical localization of growth hormone releasing hormone in human gonads. J. Endocrinol. Invest. 13: 301, 1990.
8. Moretti C., Bagnato A., Solan N., Frajese G., Catt K.J. Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation. Endocrinology 127: 2117, 1990.
9. Bagnato A., Moretti C., Frajese G., Catt K.J. Gonadotropin-induced expression of receptors for growth hormone releasing factor in cultured granulosa cells. Endocrinology 128: 2889, 1991.
10. Katz E., Ricciarelli E., Adashi E.Y. The potential relevance of growth hormone to female reproductive physiology and pathophysiology. Fertil. Steril. 59: 8, 1993.
11. Doldi N., Bassan M., Bonzi V., Ferrari A. Effects of growth hormone and growth hormone-releasing hormone on steroid synthesis in cultured human luteinizing granulosa cells. Gynecol. Endocrinol. 10: 101, 1996.
12. 17.20-lyase cytochrome P450. J. Biol. Chem. 259: 3971, 1984.
13. Spicer L.J., Langhout D.J., Alpizar E., Williams S.K., Campbell R.M., Mowles T.F., Enright W.J. Effects of growth hormone-releasing factor and vasoactive intestinal peptide on proliferation and steroidogenesis of bovine granulosa cells. Mol. Cell. Endocrinol. 83: 73, 1992.
14. Arán B., Calderón G., Moragas M., Torelló M.J., Veiga A., Barri P.N. Chromosome anomalies in mouse zygotes treated by growth hormone-releasing factor. Hum. Reprod. 7: 1394, 1992.
15. Kaganowicz A., Farkouh N.H., Frantz A.G., Blaustein A.U. Ectopic human growth hormone in ovaries and breast cancer. J. Clin. Endocrinol. Metab. 48: 5, 1979.
16. Davies T.F., Katikineni M., Chan V., Harwood J.P., Dufau M.L., Catt K.J. Lactogenic receptor regulation in hormone-stimulated steroidogenic cells. Nature 283: 863, 1980.
17. Ranke M.B., Stanley C.A., Tenore A., Rodbard D., Bongiovanni A.M., Parks J.S. Characterization of somatogenic and lactogenic binding sites in isolated rat hepatocytes. Endocrinology 99: 1033, 1976.
18. Lobie P.E., Breipohl W., Aragon J.G., Waters M.J. Cellular localization of the growth hormone receptor/binding protein in the male and female reproductive systems. Endocrinology 126: 2214, 1990.
19. Lobie P.E., Garcia-Aragon J., Wang B.S., Baumbach W.R., Waters M.J. Cellular localization of the growth hormone binding protein in the rat. Endocrinology 130: 3057, 1992.
20. Jia X.-C., Kalmijn J., Hsueh A.J.W. Growth hormone enhances follicle-stimulating hormone-induced differentiation of cultured rat granulosa cells. Endocrinology 118: 1401, 1986.
21. Hsu C.-J., Hammond J.M. Concomitant effects of growth hormone on secretion of insulin-like growth factor I and progesterone by cultured porcine granulosa cells. Endocrinology 121: 1343, 1987.
22. Mason H.D., Martikainen H., Beard R.W., Anyaoku V., Franks S. Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells. J. Endocrinol. 126: R1-R4, 1990.
23. Barreca A., Minuto F., Volpe A., Cecchelli E., Cella F., Del Monte P., Artini P., Giordano G. Insulin-like growth factor-I (IGF-I) and IGF-I binding protein in the follicular fluids of growth hormone treated patients. Clin. Endocrinol. (Oxf.) 32: 497, 1990.
24. Barreca A., Artini P.G., Del Monte P., Ponzani P., Pasquini P., Cariola G., Volpe A., Genazzani A.R., Giordano G., Minuto F. In vivo and in vitro effect of growth hormone on estradiol secretion by human granulosa cells. J. Clin. Endocrinol. Metab. 77: 61, 1993.
25. El-Roeiy A., Chen X., Roberts V.J., Shimasaki S., Ling N., LeRoith D., Roberts C.T. jr., Yen S.S.C. Expression of the genes encoding the insulin-like growth factors (IGF-I and II), the IGF and insulin receptors, and IGF-binding proteins 1-6 and the lo calization of their gene products in normal and polycystic ovary syndrome ovaries. J. Clin. Endocrinol. Metab. 78: 1488, 1994.
26. Lanzone A., Di Simone N., Castellani R., Fulghesu A.M., Caruso A., Mancuso S. Human growth hormone enhances progesterone production by human luteal cells in vitro: evidence of a synergistic effect with human chorionic gonadotropin. Fertil. Steril. 57: 92, 1992.
27. Hernandez E.R., Roberts C.T., Hurwitz A., LeRoith D., Adashi E.Y. Rat ovarian insulin-like growth factor II gene expression is theca-interstitial cell-exclusive: hormonal regulation and receptor distribution. Endocrinology 127: 3249, 1990.
28. Geisthovel F., Moretti-Rojas I., Asch R.H., Rojas F.J. Expression insulin-like growth factor-II (IGF-II) messenger ribonucleic acid (mRNA), but not IGF-I mRNA, in human preovulatory granulosa cells. Hum. Reprod. 4: 899, 1989.
29. Poretsky L., Kalin M.F. The gonadotropic function of insulin. Endocr. Rev. 8: 132, 1987.
30. Erickson G.F., Garzo V.G., Magoffin D.A. Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells. J. Clin. Endocrinol. Metab. 69: 716, 1989.
31. Christman G.M., Halme J.K. Growth hormone: revisited. Fertil. Steril. 57: 12, 1992.
32. Bergh C., Olsson J.-H., Hillensjö T. Effect of insulin-like growth factor I on steroidogenesis in cultured human granulosa cells. Acta Endocrinol. (Copenh.) 125: 177, 1991.
33. Adashi E.Y., Resnick C.E., D'Ercole A.J., Svoboda M.E., Van Wyk J.J. Insulin-like growth factors as ovarian regulators of granulosa cell growth and function. Endocr. Rev. 6: 400, 1985.
34. Zapf J., Rinderknecht E., Humbel R.E., Froesch E.R. Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications. Metabolism 27: 1803, 1978.
35. Phillips L.S., Vassilopoulou-Sellin R. Somatomedins. N. Engl. J. Med. 302: 371, 1980.
36. Davoren J.B., Hsueh A.J.W. Growth hormone increases ovarian levels of immunoreactive somatomedin C/insulin-like growth factor I in vivo. Endocrinology 118: 888, 1986.
37. Homburg R., West C., Torresani T., Jacobs H.S. Cotreatment with human growth hormone and go nadotropins for induction of ovulation: a controlled clinical trial. Fertil. Steril. 53: 254, 1990.
38. Owen E. J., Torresani T., West C., Mason B. A., Jacobs H.S. Serum and follicular fluid insulin like growth factors I and II during growth hormone cotreatment for in-vitro fertilization and embryo transfer. Clin. Endocrinol. (Oxf.) 35: 327, 1991.
39. Davoren J.B., Hsueh A.J.W., Li C.H. Somatomedin C augments FSH-induced differentiation of cultured rat granulosa cells. Am. J. Physiol. 249: E26, 1985.
40. Blumenfeld Z. Growth hormone-A cogonadotropin? Its role in ovulation induction. J. In Vitro Fert. Embryo Transfer 8: 127, 1991.
41. Balboni G.C., Vannelli G.B., Barni T., Orlando C., Serio M. Transferrin and somatomedin C receptors in the human ovarian follicles. Fertil. Steril. 40: 706, 1987.
42. Gates G.S., Bayer S., Siebel M., Poretsky L., Flier J.S., Moses A.C. Characterization of insulin-like growth factor binding to human granulosa cells obtained during in-vitro fertilization. J. Recept. Res. 7: 885, 1987.
43. Hsu C.-J., Hammond J.M. Gonadotropin and estradiol stimulate immunoreactive insulin-like growth factor-I production by porcine granulosa cells in vitro. Endocrinology 120: 198, 1987.
44. Mondschein J.S., Hammond J.M. Growth factors regulate immunoreactive insulin-like growth factor-I production by cultured porcine granulosa cells. Endocrinology 723: 463, 1988.
45. Apa R., Di Simone N., Ronsisvalle E., Miceli F., de Feo D., Caruso A., Lanzone A., Mancuso S. Insulin-like growth factor (IGF)-I and IGF-II stimulate progesterone production by human luteal cells: role of IGF-I as mediator of growth hormone action. Fertil. Steril. 66: 235, 1996.
46. Mondschein J.S., Canning S.F., Miller D.Q., Hammond J.M. Insulin-like growth factors (IGFs) as autocrine/paracrine regulators of granulosa cell differentiation and growth: studies with a neutralizing monoclonal antibody to IGF-I. Biol. Reprod. 41: 79, 1989.
47. SSC, in human steroidogenic tissue. Proc. Natl. Acad. Sci. USA 84: 1590, 1987.
48. Ramasharma K., Li C.H. Human pituitary and placental hormone control of human insulin-like growth factor II secretion in human granulosa cells. Proc. Natl. Acad. Sci. USA 84: 2643, 1987.
49. Ramasharma K., Cabrera C.M., Li C.H. Identification of insulin-like growth factor-II in human seminal and follicular fluids. Biochem. Biophys. Res. Commun. 140: 536, 1986.
50. Friedman A.J., Rein M.S., Pandian M.R., Barbieri R.L. Fasting serum growth hormone insulin-like growth factor-I and -II concentrations in women with leiomyomata uteri treated with leuprolide acetate or placebo. Fertil. Steril. 53: 250, 1990.
51. Carlsson B., Bergh C., Bentham J., Olsson J.-H., Norman M.R., Billig H., Roos P., Hillensjö T. Expression of functional growth hormone receptors in human granulosa cells. Hum. Reprod. 7: 1205, 1992.
52. Ovesen P., Ingerslev H.J., Ørskov H., Ledet T. Effect of growth hormone on steroidogenesis, insulin-like growth factor-I (IGF-I) and IGF binding protein-I production and DNA synthesis in cultured human luteinized granulosa cells. J. Endocrinol. 140: 313, 1994.
53. Fowler P.A., Templeton A. Ovarian response to gonadotrophins: effects of growth hormone. Clin. Endocrinol. (Oxf.) 35: 117, 1991
54. Jacobs H.S., Bouchard P., Conway G.S., Homburg R., Lahlou N., Mason B., Ostergaard H., Owen E.J. Role of growth hormone in infertility. Horm. Res. 36(suppl. 1): 61, 1991.
55. Shoham Z., Homburg R., Owen E.J., Conway G.S., Ostergaard H., Jacobs H.S. The role of treatment with growth hormone in infertile patients. Baillieres Clin. Obstet. Gynaecol. 6: 267, 1992.
56. Meirow D., Laufer N., Schenker J.G. Ovulation induction in in vitro fertilization. Gynecol. Endocrinol. 6: 211, 1992.
57. Jacobs H.S. Growth hormone and ovulation: is there an indication for treatment of infertile women with growth hormone? Horm. Res. 38 (suppl. 1): 14, 1992.
58. Homburg R. Ovulation induction in gonadotrophin-resistant women. Baillieres Clin. Obstet. Gynaecol. 7: 349, 1993.
59. Katz E. The use of growth hormone treatment for ovulation induction. Curr. Opin. Obstet. Gynecol. 5: 234, 1993.
60. Corpas E., Harman S.M., Blackman M.R. Human growth hormone and human aging Endocr. Rev. 14: 20, 1993.
61. Meirow D., Laufer N., Schenker J.G. Ovulation induction in polycystic ovary syndrome: a review of conservative and new treatment modalities. Eur. J. Obstet. Gynecol. Reprod. Biol. 50: 123, 1993.
62. Levron J., Lewit N., Erlik Y., Itskovitz-Eldor J. No beneficial effects of human growth hormone therapy in normal ovulatory patients with a poor ovarian response to gonadotropins. Gynecol. Obstet. Invest. 35: 65, 1993.
63. Lippe B.M., Nakamoto J.M. Conventional and nonconventional uses of growth hormone. Recent Prog. Horm. Res. 48: 179, 1993.
64. Blumenfeld Z., Amit T. The role of growth hormone in ovulation induction. Ann. Med. 26: 249, 1994.
65. Ben-Rafael Z., Orvieto R., Feldberg D. The poor-responder patient in an in vitro fertilization-embryo transfer (IVF-ET) program. Gynecol. Endocrinol. 8: 277, 1994.
66. Homburg R., Ostergaard H. Clinical applications of growth hormone for ovarian stimulation Hum. Reprod. Update 1: 26, 1995.
67. Homburg R., Ben-Rafael Z. The place of cotreatment with growth hormone and human menopausal gonadotropin (hMG) in ovarian stimulation J. Assist. Reprod. Genet. 13: 371, 1996.
68. Homburg R. Growth hormone and fertility - Clinical studies. Horm. Res. 45: 81, 1996.
69. Blumenfeld Z, Lunenfeld B. The potentiating effect of growth hormone on follicle stimulation with human menopausal gonadotropin in a panhypopituitary patient. Fertil. Steril. 52: 328, 1989.
70. Ibrahim Z.H.Z., Matson P.L., Buck P., Lieberman B.A. The use of biosynthetic human growth hormone to augment ovulation induction with buserelin acetate/human menopausal gonadotropin in women with a poor ovarian response. Fertil. Steril. 55: 202, 1991.
71. Owen E.J., Shoham Z., Mason B.A., Ostergaard H., Jacobs H.S. Cotreatment with growth hormone, after pituitary suppression, for ovarian stimulation in in vitro fertilization: a randomized, double-blind, placebo-control trial. Fertil. Steril. 56: 1104, 1991.
72. European and Australian Multicenter Study. Cotreatment with growth hormone and gonadotropin for ovulation induction in hypogonadotropic patients: a prospective, randomized, placebo-controlled, dose-response study. Fertil. Steril. 64: 917, 1995.
73. Volpe A., Coukos G., Barreca A., Artini P.G., Minuto F., Giordano G., Genazzani A.R. Ovarian response to combined growth hormone-gonadotropin treatment in patients resistant to induction of superovulation. Gynecol. Endocrinol. 3: 125, 1989.
74. Hughes S.M., Huang Z.H., Morris I.D., Matson P.L., Buck P., Lieberman B.A. A double-blind cross-over controlled study to evaluate the effect of human biosynthetic growth hormone on ovarian stimulation in previous poor responders to in-vitro fertilization. Hum. Reprod. 9: 13, 1994.
75. Bergh C., Hillensjö T., Wikland M., Nilsson L., Borg G., Hamberger L. Adjuvant growth hormone treatment during in vitro fertilization: a randomized, placebo-controlled study. Fertil. Steril. 62, 113, 1994.
76. Dor J., Seidman D.S., Amudai E., Bider D., Levran D., Mashiach S. Adjuvant growth hormone therapy in poor responders to in-vitro fertilization: a prospective, randomized, placebo-controlled, double-blind study. Hum. Reprod. 10: 40, 1995.
77. Shaker A.G., Fleming R., Jamieson M.E., Yates R.W.S., Coutts J.R.T. Absence of effect of adjuvant growth hormone therapy on follicular responses to exogenous gonadotrophins in women: normal and poor responders. Fertil. Steril. 50: 919, 1992.
78. Levy T., Limor R., Villa Y., Eshel A., Eckstein N., Vagman I., Lidor A., Ayalon D. Another look at cotreatment with growth hormone and human menopausal gonadotrophins in poor ovarian responders. Hum. Reprod. 8: 834, 1993.
79. Owen E.J., West C., Mason B.A., Jacobs H.S. Cotreatment with growth hormone of sub-optimal responders in IVF-ET. Hum. Reprod. 6: 524, 1991.
80. Hugues J.-N., Torresani T., Herve F., Martin-Pont B., Tamboise A., Santarelli J. Interest of growth hormone-releasing hormone administration for improvement of ovarian responsiveness to gonadotropins in poor responder women. Fertil. Steril. 55: 945, 1991.
81. Garcia J.E., Jones G.S., Acosta A.A., Wright G. jr. Human menopausal gonadotropin human chorionic gonadotropin follicular maturation for oocyte aspiration: phase II. Fertil. Steril. 39: 174, 1983.
82. Ben-Rafael Z., Feldberg D. The poor-responder patient in an in vitro fertilization-embryo transfer program. J. Assist. Reprod. Genet. 10: 118, 1993.
83. Cassar J., Verco G.G., Joplin G.F. Successful pregnancy induced by human menopausal gonadotropin in a patient with growth hormone deficiency and primary amenorrhea: a case report. Br. J. Obstet. Gynaecol. 87: 337, 1980.
84. Dawood M.Y., Jarrett J.C., Choe J.K. Partial hypopituitarism and hyperprolactinemia: successful induction of ovulation with bromocriptine and human menopausal gonadotropins. Fertil. Steril. 38: 415, 1982.
85. Homburg R., Eshel A., Abdalla H.I., Jacobs H.S. Growth hormone facilitates ovulation induction by gonadotrophins. Clin. Endocrinol. 29: 113, 1988.
86. Homburg R., West C., Torresani T., Jacobs H.S. A comparative study of single-dose growth hormone therapy as an adjuvant to gonadotropin treatment for ovulation induction. Clin. Endocrinol. 32: 781, 1990.
87. Burger H.G., Kovacs G.T., Poison D.M., McDonald J., McCloud P.I., Harrop M., Colman P., Healy D.L. Ovarian sensitization to gonadotrophins by human growth hormone. Persistence of the effect beyond the treated cycle. Clin. Endocrinol. (Oxf.) 35: 119, 1991.
88. Homburg R., West C., Ostergaard H., Jacobs H.S. Combined growth hormone and gonadotropin treatment for ovulation induction in patients with non-responsive ovaries. Gynecol. Endocrinol. 5: 33, 1991.
89. Volpe A., Coukos G., Artini P.G., Silferi M., Petraglia F., Boghen M., D'Ambrogio G., Genazzani A.R. Pregnancy following combined growth hormone-pulsatile GnRH treatment in a patient with hypothalamic amenorrhea. Hum. Reprod. 5: 345, 1990.
90. Adams J., Franks S., Polson D.W., Mason H.D., Abdulwahid N., Tucker M., Morris D.V., Price J., Jacobs H.S. Multifollicular ovaries: clinical and endocrine features and response to pulsatile gonadotropin releasing hormone. Lancet 2: 1375, 1985.
91. Volpe A., Artini P.G., Barreca A., Minuto F., Coukos G., Genazzani A.R. Effects of growth hormone administration in addition to gonadotrophins in normally ovulating women and polycystic ovary syndrome (PCO) patients. Hum. Reprod. 7: 1347, 1992.
92. Homburg R., Levy T., Ben-Rafael Z. Adjuvant growth hormone for induction of ovulation with gonadotrophin-releasing hormone agonist and gonadotrophins in polycystic ovary syndrome: a randomized, double-blind, placebo controlled trial. Hum. Reprod. 10: 2550, 1995.
93. Quigley M., Rakoff J.S., Yen S.S.C. Increased luteinizing hormone. Sensitivity to dopamine inhibition in polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 52: 231, 1981.
94. Shoupe D., Lobo R. Evidence for an altered cathecolamine metabolism in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 150: 566, 1984.
95. Cumming D.C., Reid R.L., Quigley M. Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome. Clin. Endocrinol. (Oxf.) 20: 643, 1984.
96. Wortsman J., Wehrenberg W.B., Gavin III J.R., Allen J.P. Elevated levels of β-endorphin and γ3-melanocyte stimulating hormone in the polycystic ovarian syndrome. Obstet. Gynecol. 63: 630, 1984.
97. Anaplitou L.G., Syrygos K., Panayotakopoulos G., Kalos A., Batrinos M.L. Paradoxical growth hormone response following thyroid-stimulating hormone administration in the polycystic ovarian syndrome. Norm. Res. 31: 119, 1989.
98. Chang R.J., Nakamura R.M., Judd H.L., Kaplan S.A. Insulin resistance in nonobese patients with polycystic ovarian syndrome. J. Clin. Endocrinol. Metab. 57: 356, 1983.
99. Lanzone A., Fulghesu A.M., Pappalardo S., Proto C., Le Donne M., Andreani C.L., Muscatello R., Caruso A., Mancuso S. Growth hormone and somatomedin-C secretion in patients with polycystic ovarian disease. Their relationships with hyperinsulinism and hyperandrogenism. Gynecol. Obstet. Invest. 29: 149, 1990.
100. Burghen G.A., Givens J.R., Kitabchi A.E. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease. J. Clin. Endocrinol. Metab. 50: 113, 1980.
101. Urdl W. Polycystic ovarian disease: endocrinological parameters with specific reference to growth hormone and somatomedin-C. Arch. Gynecol. Obstet. 243: 13, 1988.
102. Artini P.G., Battaglia C., D'Ambrogio G., Barreca A., Droghini F., Volpe A., Genazzani A.R. Relationship between human oocyte maturity, fertilization and follicular fluid growth factors. Hum. Reprod. 9: 902, 1994.
103. Hughes S.M., Huang Z.H., Matson P.L., Buck P., Lieberman B.A., Morris I.D. Clinical and endocrinological changes in women following ovulation induction using buserelin/acetate human menopausal gonadotrophin augmented with biosynthetic human growth hormone. Hum. Reprod. 7: 770, 1992.
104. Younis J.S., Simon A., Koren R., Dorembus D., Schenker J.G., Laufer N. The effect of growth hormone supplementation on in-vitro fertilization outcome: a prospective randomized placebo controlled double-blind study. Fertil. Steril. 58: 575, 1992.
105. Tapanainen J., Martikainen H., Voutilainen R., Orava M., Ruokonen A., Rönnberg L. Effect of growth hormone administration on human ovarian function and steroidogenic gene expression in granulosa-luteal cells. Fertil. Steril. 58: 726, 1992.
106. Tzeng C.R., Chien L.W., Cheng Y.F., Chang S.R., Chen A.C. Enhancement of IVF pregnancy rates by cotreatment with low dose growth hormone. J. Assist. Reprod. Genet. 10 (Suppl.): 111, 1993.
107. Volpe A., Coukos G., Barreca A., Giordano G., Artini P.G., Genazzani A.R. Clinical use of growth hormone-releasing factor for induction of superovulation. Hum. Reprod. 6: 1228, 1991.
108. Tulandi T., Falcone T., Guyda H., Hemmings R., Billiar R., Morris D. Effect of synthetic growth hormone-releasing factor in women treated with gonadotrophin. Hum. Reprod. 8: 525, 1993.
109. Genazzani A.R., Artini P.G., Battaglia C., Droghini F., Mancini A.C., D'Ambrogio G. Clinical effects of GRF plus pFSH in poor-responder patients. In: Andreoli M., Shields M. (Eds.), Highlights in molecular and clinical endocrinology, Frontiers in Endocrinology. Ares-Serono Symposia Publications, Rome, 1994, vol. 9, p. 249.
110. Jørgensen J.O. Human growth hormone reptecement therapy: pharmacological and clinical aspects. Endocr. Rev. 12: 189, 1991.
111. Blumenfeld Z., Dirnfeld M., Gonen Y., Abramovici H. Growth hormone cotreatment for ovulation induction may enhance conception in the cotreatment and succeeding cycles, in clonidine negative but not clonidine positive patients. Hum. Reprod. 9: 209, 1994.
112. Ituarte E.A., Petrini J., Hershman J.M. Acromegaly and colon cancer. Ann. Intern. Med. 101: 627, 1984.
113. Ogilvy-Stuart A.L., Shalet S.M. Tumour occurrence and recurrence. Horm. Res. 38(suppl. 1):50, 1992.
114. Parker M.L., Hammond J.M., Daughaday W.H. The arginine provocative test: an aid in the diagnosis of hyposomatotropism. J. Clin. Endocrinol. Metab. 27: 1129, 1967.
115. Ghigo E., Goffi S., Nicolosi M., Arvat E., Valente F., Mazza E., Ghigo M.C., Camanni F. Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man. J. Clin. Endocrinol. Metab. 71: 1481, 1990.
116. Davis T.M.E., Burrin J.M., Bloom S.R. Growth hormone (GH) release in response to GH-releasing hormone in man is 3-fold enhanced by galanin. J. Clin. Endocrinol. Metab. 65: 1248, 1987.
117. Fass B., Lippe B.M., Kaplan S.A. Relative usefulness of three growth hormone stimulation screening tests. Am, J. Dis. Child. 133: 931, 1979.
118. Shibasaki T., Hotta M., Masuda A., Imaki T., Obara N., Demura H., Ling N., Shizume K. Plasma GH response to GRH and insulin induced hypoglycemia in man. J. Clin. Endocrinol. Metab. 60: 1265, 1985.
119. Lancranjan I., Marbach P. New evidence for growth hormone modulation by alpha-adrenergic system in man. Metabolism 26: 1225, 1977.
120. Slover R.H., Klingensmith G.J., Gotlin R.W., Radcliffe J. A comparison of clonidine and standard provocative agents of growth hormone. Am. J. Dis. Child. 138: 314, 1984.
121. Frasier S.D. A review of growth hormone stimulation tests in children. Pediatrics 53: 929, 1974.
122. Moll G.W. jr., Rosenfield R.L., Fang V.S. Administration of low-dose estrogen rapidly and directly stimulates growth hormone production. Am. J. Dis. Child. 140: 124, 1986.
123. Arends J., Wagner W.-L., Willms B.L. Cholinergic muscarinic receptor blockade suppresses arginine- and exercise-induced growth hormone secretion in type I diabetic subjects. J. Clin. Endocrinol. Metab. 66: 389, 1988.
124. Alba-Roth J., Müller O.A., Schopohl J., von Werder K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 67: 1186, 1988.
125. Menashe Y., Lunenfeld B., Pariente C., Frenkel Y., Mashiach S. Can growth hormone increase, after clonidine administration, predict the dose of human menopausal hormone needed for induction of ovulation? Fertil. Steril. 53: 432, 1990.
126. Ovesen P., Maller J., Møller N., Christiansen J.S., Ørskov H., Jørgensen J.O.L. Growth hormone secretory capacity and serum insulin-like growth factor I levels in primary infertile, anovulatory women with regular menses. Fertil. Steril. 57: 97, 1992.
127. Salat-Baroux J., Rotten D., Alvarez S., Antoine J.M. Comparison of growth hormone responses to growth hormone-releasing factor and clonidine in women with normal or poor ovarian response to gonadotropin stimulation. Fertil. Steril. 60: 791, 1993.
128. Stone B.A., Marrs R.P. Ovarian response to menopausal gonadotropins in groups of patients with differing basal growth hormone levels. Fertil. Steril. 58: 32, 1992.